The person you're replying wrote no one wants to study the effects of nootropics in healthy adults. Sick people with insurance, particularly chronically ill on

The person you're replying wrote no one wants to study the effects of nootropics in healthy adults. Sick people with insurance, particularly chronically ill ones, or those with illnesses that threaten their lives, are where I'd imagine the majority of money is made. You could probably argue treating the ill is more psychologically impactful work too. That's going to skew where researcher's focus their attention, especially if their work is funded by private industry.